(E/Z)-Ensifentrine is a potent and selective PDE3/4 inhibitor that acts as a long-acting inhibitor of the phosphodiesterase enzymes PDE-3 and PDE-4, producing both bronchodilator and anti-inflammatory effects. It is being developed by Verona Pharma as a potential treatment for asthma and hay fever and is currently in clinical trials.
Molecular Weight:
477.56
CAS Number:
[298680-25-8]
Formula:
C26H31N5O4
Target:
Others|||PDE
T69491
* VAT and and shipping costs not included. Errors and price changes excepted
